The Ensign Group, Inc. $ENSG Stock Sold by Copeland Capital Management LLC

Key Points

• Copeland Capital Management reduced its Ensign Group stake by 2.6%, selling 14,686 shares and retaining 554,210 shares valued at approximately $95.3 million. Institutional investors collectively own 96.12% of the company.
• Ensign reported quarterly EPS of $1.92, beating estimates of $1.80, while revenue rose 16.7% year over year to $1.44 billion. The company also declared a $0.065 quarterly dividend, equivalent to a 0.2% yield.
• Analysts maintain a generally positive view, with a “Moderate Buy” consensus and an average price target of $216.25 versus the stock’s $173.26 opening price. However, investor lawsuits alleging misleading disclosures about care quality, staffing and billing present potential legal and reputational risks.

Copeland Capital Management LLC lessened its position in shares of The Ensign Group, Inc. (NASDAQ:ENSG - Free Report) by 2.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 554,210 shares of the company's stock after selling 14,686 shares during the period. The Ensign Group makes up about 2.1% of Copeland Capital Management LLC's holdings, making the stock its 3rd biggest position. Copeland Capital Management LLC owned 0.95% of The Ensign Group worth $95,324,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Cedar Mountain Advisors LLC bought a new position in The Ensign Group in the 1st quarter valued at $32,000. Transamerica Financial Advisors LLC bought a new position in shares of The Ensign Group in the second quarter worth $26,000. Monetary Solutions Ltd bought a new position in shares of The Ensign Group in the fourth quarter worth $30,000. Bayban bought a new position in shares of The Ensign Group in the fourth quarter worth $31,000. Finally, Caitlin John LLC purchased a new stake in shares of The Ensign Group in the second quarter worth $31,000. 96.12% of the stock is currently owned by hedge funds and other institutional investors.

The Ensign Group Price Performance

Shares of NASDAQ:ENSG opened at $173.26 on Wednesday. The company's fifty day moving average price is $175.68 and its 200-day moving average price is $175.93. The firm has a market capitalization of $10.10 billion, a price-to-earnings ratio of 27.16, a PEG ratio of 1.65 and a beta of 0.66. The Ensign Group, Inc. has a one year low of $141.58 and a one year high of $218.00. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.21 and a quick ratio of 1.21.

The Ensign Group (NASDAQ:ENSG - Get Free Report) last posted its quarterly earnings data on Monday, July 27th. The company reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.80 by $0.12. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The firm had revenue of $1.44 billion for the quarter, compared to analysts' expectations of $1.44 billion. The business's quarterly revenue was up 16.7% on a year-over-year basis. During the same quarter last year, the company posted $1.59 EPS. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. On average, equities research analysts anticipate that The Ensign Group, Inc. will post 7.04 earnings per share for the current fiscal year.

The Ensign Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Saturday, October 31st. Stockholders of record on Wednesday, September 30th will be issued a $0.0650 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $0.26 annualized dividend and a dividend yield of 0.2%. The Ensign Group's dividend payout ratio (DPR) is currently 4.08%.

Insider Activity

In related news, Director John Agwunobi sold 392 shares of the business's stock in a transaction dated Monday, July 20th. The stock was sold at an average price of $171.06, for a total transaction of $67,055.52. Following the transaction, the director owned 9,503 shares in the company, valued at $1,625,583.18. The trade was a 3.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 4.00% of the company's stock.

Analyst Upgrades and Downgrades

ENSG has been the subject of several research analyst reports. Royal Bank Of Canada reissued an "outperform" rating and set a $228.00 price objective on shares of The Ensign Group in a research note on Tuesday, July 28th. Truist Financial boosted their target price on The Ensign Group from $202.00 to $207.00 and gave the stock a "hold" rating in a research report on Thursday, July 30th. Wall Street Zen upgraded The Ensign Group from a "hold" rating to a "buy" rating in a research note on Saturday, October 3rd. Finally, Weiss Ratings raised The Ensign Group from a "buy (b-)" rating to a "buy (b)" rating in a report on Thursday, October 8th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $216.25.

More The Ensign Group News

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: No new positive operating or financial catalyst was reported in the latest articles. Ensign’s most recent quarterly results, provided as background, showed earnings above analyst expectations and 16.7% year-over-year revenue growth.
• Neutral Sentiment: Kaplan Fox, Rosen Law Firm, Faruqi & Faruqi, Bronstein Gewirtz & Grossman, Howard G. Smith, and other firms are soliciting investors who purchased Ensign securities from February 10, 2022, through June 18, 2026, to participate in or seek leadership of the action. These are investor-notification announcements and do not establish that the allegations are true. Kaplan Fox investor notice
• Negative Sentiment: The lawsuit and related notices allege that Ensign and certain executives misled investors about patient neglect, understaffing, quality and staffing data, improper billing, and an administrator-license rental arrangement. The allegations reportedly followed disclosures that contributed to significant stock declines, including an approximately 8% drop cited in one notice. If substantiated, the claims could lead to litigation costs, regulatory scrutiny, reputational damage, and weaker investor confidence. Bleichmar Fonti & Auld lawsuit report

About The Ensign Group

The Ensign Group, Inc NASDAQ: ENSG is a healthcare services company that operates through a network of skilled nursing, rehabilitation and senior living facilities. Its centers provide post-acute care, including nursing services, physical, occupational and speech therapy, short-term rehabilitation, and long-term residential care for older adults and patients recovering from illness, injury or surgery.

The company also provides home health and hospice services, as well as a range of ancillary services supporting post-acute care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.